pharmacoeconomic methods

[Guest guest]

Dear sir

welcome back...............

In continuation to previous discussion

This is one of the another parameter need to be considered in BoI or CoI studies:

Morbidity:

Morbidity describes the occurrence of disease or disability in a population. Compared to mortality data, data on morbidity is comparatively limited in scope and quality. Morbidity is sometimes difficult to define, e.g. measurement scales might be needed and thresholds defined for what constitutes clinical depression, hypertension or obesity for the purposes of clinical trials or for formal epidemiological studies.

Tarun Wadhwa